Navigation Links
Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
Date:1/20/2009

PHILADELPHIA, Jan. 20 /PRNewswire/ -- Mealey's Conferences (now HB Litigation Conferences) released its upcoming schedule of CLE accredited teleconferences for tort litigators, plus a professional development opportunity for women in the legal profession.

     Upcoming teleconferences include:

     January 22 - Asbestos Gaskets: Exposure and the State of the Art.

     February 5 - Duragesic/Fentanyl Patch.

February 5 - Nanotechnology: Is it the Next Plastics or the Next Asbestos?

February 23 - Hot Topics in Pharma Litigation: Byetta, Digitek, Yasmin, NuvaRing & More.

February 24 - Defense Perspectives on Attorney General Pharmaceutical Claims.

February 24 - Construction Defect Litigation: Delay, Disruption, Collection Claims in Foreclosure & Contract Disputes.

February 26 - International Asbestos Litigation.

February 12 - Effective Negotiating Skills for Women Lawyers (CLE depends on state bar rules).

Not only can attorneys use these programs to educate practice teams, but can benefit from 2-for-1 pricing (promo code MASSTORTS141 required).

Interested attorneys are encouraged to visit http://www.LitigationConferences.com for more info, plus free articles and audio/video clips from the company's archives covering insurance, reinsurance, toxic torts, construction litigation and complex commercial and financial litigation. Recent audio posts include one of plaintiff attorney Mark Lanier speaking on asbestos last year. New video posts, more than a dozen, are available from last week's banking litigation conference.

    Call us at 484-324-2755 x200.  Email
Kathleen.McFadden@litigationconferences.com or
Lynnsey.PerrinHee@litigationconferences.com.

Teleconferences are accredited for 1.5CLEs and take place from 2pm-3:40pm EST except where noted.

HB Litigation Conferences, fka Mealey's Conferences, is a leading provider of litigation conferences, seminars, and teleconferences with a rich archive of legal education materials and multimedia content. All programs are fully accredited for continuing legal education. For general inquiries write to info@litigationconferences.com.

     CONTACT
     Lynnsey Perrin Hee
     HB Litigation Conferences
     fka Mealey's Conferences
     lynnsey.perrinhee@litigationconferences.com
    (484) 324-2755 x210

'/>"/>
SOURCE HB Litigation Conferences: fka Mealey's Conferences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper ... information on the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent ... profiling of therapeutic antibodies. , To meet this demand, the team at ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered ... for high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration ...
Breaking Biology Technology:
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
Breaking Biology News(10 mins):